2.To Be a Gastroenterologist Who Communicates Well with Patients.
The Korean Journal of Gastroenterology 2012;60(3):162-165
There are many reasons why doctors would not to be able to communicate with patients. First, medicine is science or humanity? Although object of medicine is human, modern medicine tends to regard human as broken machine. Second, gastroenterologists are overloaded by treatment of patients, providing education, attending academic conference, and writing papers. Above all things, it is much worse for gastroenterologists because of endoscopic procedures. The other problem is attitude of modern society about human suffering. Sufferings come from not only body but also mind or spirit. Although there are may difficult problems, if doctors listen to patients' history by their side, it will help to restore their faith. In addition, we need humanity education and improvement plans for medical service system.
Delivery of Health Care
;
Education, Medical, Continuing
;
Gastrointestinal Diseases/*psychology
;
Humans
;
Physician-Patient Relations
;
Physicians/*psychology
3.Can Ki-67 Expression Predict the Prognosis in Low Grade Rectal Carcinoid Tumor?.
The Korean Journal of Gastroenterology 2013;61(2):61-62
No abstract available.
Carcinoid Tumor/*diagnosis
;
Female
;
Humans
;
Ki-67 Antigen/*metabolism
;
Male
;
Rectal Neoplasms/*diagnosis
4.Current Status of Chemotherapy in Colorectal Cancer: Updated Treatment Strategies
The Korean Journal of Gastroenterology 2024;84(3):123-127
Colorectal cancer remains a significant health burden in South Korea, being the third most diagnosed cancer in the country. Despite advances in treatment, patients with metastatic colorectal cancer still face limited survival rates, with resection often deemed impossible for the majority. This review discusses the current state of chemotherapy in colorectal cancer treatment, focusing on both adjuvant chemotherapy post-surgery and palliative chemotherapy for metastatic cases. The article highlights recent updates in treatment guidelines, including the use of immunotherapy and the role of circulating tumor DNA (ctDNA) in personalized medicine. The integration of these novel approaches aims to enhance treatment efficacy, improve patient survival, and reduce recurrence rates, paving the way for more tailored and effective therapeutic strategies in colorectal cancer management.
5.Proper Treatment Option for Small Rectal Neuroendocrine Tumors Using Precut Endoscopic Mucosal Resection.
Clinical Endoscopy 2017;50(6):516-517
No abstract available.
Neuroendocrine Tumors*
6.Target Therapy in Unresectable or Metastatic Colorectal Cancer.
The Korean Journal of Gastroenterology 2016;68(6):303-311
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in Korea. Despite recent developments in the treatment of CRC, the median overall survival time in patients with metastatic CRC is less than 30 months. The biologic agents that target the epidermal growth factor receptor (EGFR) or vascular endothelial growth factor (VEGF) have proven clinical benefits in the treatment of patient with metastatic CRC. Anti-EGFR agents, including cetuximab and panitumumab, as well as anti-VEGF agents, including bevacizumab, aflibercept, ramucirumab, and regorafenib have been shown to extend survival in combination with cytotoxic chemotherapy. In particular, the addition of anti-EGFR agents has demonstrated significant efficacy in patients with the RAS wild-type metastatic CRC. In the future, building a personalized treatment strategy, according to the clinical characteristics and biologic features of patients with unresectable or metastatic CRC, will be necessary. In this review, we summarized the mechanisms of target therapy, the results of main clinical trials, and the guideline of clinical practice in patients with unresectable or metastatic CRC.
Bevacizumab
;
Biological Factors
;
Cetuximab
;
Colorectal Neoplasms*
;
Drug Therapy
;
Humans
;
Korea
;
Molecular Targeted Therapy
;
Neoplasm Metastasis
;
Receptor, Epidermal Growth Factor
;
Vascular Endothelial Growth Factor A
7.Tips and Tricks for Better Endoscopic Treatment of Colorectal Tumors: Usefulness of Cap and Band in Colorectal Endoscopic Mucosal Resection.
Clinical Endoscopy 2013;46(5):492-494
Endoscopic mucosal resection (EMR) is an endoscopic alternative to surgical resection of mucosal and submucosal neoplastic lesions. Prior to the development of knives, EMR could be performed with accessories to elevate the lesion. After the development of various knives, en bloc resection was possible without other accessories. So, recently, simple snaring without suction or endoscopic submucosal dissection using knife in the epithelial lesions such as adenoma or early mucosal cancer has been performed. However, for easy and complete resection of subepithelial lesions such as carcinoid tumor, a few accessories are needed. Complete resection of rectal carcinoid tumors is difficult to achieve with conventional endoscopic resection techniques because these tumors often extend into the submucosa. The rate of positive resection margin for tumor is lower in the group of EMR using a cap (EMR-C) or EMR with a ligation device (EMR-L) than conventional EMR group. EMR-C and EMR-L (or endoscopic submucosal resection with a ligation device) may be a superior method to conventional EMR for removing small rectal carcinoid tumors.
Adenoma
;
Carcinoid Tumor
;
Ligation
;
SNARE Proteins
;
Suction
9.Effect of 15 Minutes Brief Education for Medical Personnel in Diagnosing Barrett's Esophagus.
Kwang Il SEO ; Moo In PARK ; Seun Ja PARK ; Won MOON ; Sung Eun KIM ; You Jin HAN
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2016;16(1):26-30
BACKGROUND/AIMS: The higher prevalence of gastroesophageal reflux disease has preceded the increase of Barrett's esophagus and esophageal adenocarcinoma in Western countries. An increase of Barrett's esophagus and esophageal adenocarcinoma can also be predicted due to the increase of gastroesophageal reflux disease in Asia. Therefore, the ability of endoscopists to detect Barrett's esophagus can be important in the future. The aim of this study was to examine whether a short education program could improve the ability of gastrointestinal endoscopists and nurses to detect Barrett's esophagus. MATERIALS AND METHODS: Endoscopists and nurses of Gastrointestinal Endoscopic Center in Kosin Uinversity Gospel Hospital were enrolled in this study. Endoscopic images of biopsy proven Barrett's esophagus and normal gastroesophageal junction were obtained with conventional endoscopy. Thirty-seven still images of conventional endoscopy were used for slide test before and after 15 minutes education on Barrett's esophagus. RESULTS: Diagnostic ability of the doctor group after education did not changed (pre-education 79.6% vs. post-education 79.3%, P=0.906). Nurse group showed improved diagnostic ability for Barrett's esophagus after education (pre-education 68.7% vs. post-education 75.5%, P=0.008). After a short education program, inter-observer agreement of endoscopic diagnosis of Barrett's esophagus was improved in both doctor and nurse groups (doctor inter-observer correlation coefficient [ICC], 0.684→0.879; nurse ICC, 0.524→0.862). CONCLUSIONS: Even a short education program can improve the diagnostic ability, especially inter-observer agreement of endoscopic diagnosis for Barrett's esophagus. Further studies are needed to establish a role of education to improve diagnostic ability of Barrett's esophagus.
Adenocarcinoma
;
Asia
;
Barrett Esophagus*
;
Biopsy
;
Diagnosis
;
Education*
;
Endoscopy
;
Esophagogastric Junction
;
Gastroesophageal Reflux
;
Prevalence
10.A Case of Ischemic Colitis Related with Usual Dosage of Ibuprofen in a Young Man.
Eun Jeong KIM ; Moo In PARK ; Seun Ja PARK ; Won MOON ; Go Eun YEO ; Weon Hyoung LEE
Kosin Medical Journal 2014;29(2):147-150
Ischemic colitis is a medical condition in which inflammation and injury of the large intestine result from inadequate blood supply. Although uncommon in the general population, ischemic colitis occurs with greater frequency in the elderly, and is the most common form of bowel ischemia. Other possible causes include medications such as NSAIDs(non-steroidal antiinflammatory drugs), oral contraceptives, diuretics and others. In recent years, many of NSAID use in young age can cause ischemic lesions, but it is not common. Here we report a case of ischemic colitis in a 31-year-old man who had no specific medical history except taking 200mg of ibuprofen three times a day for seven days. It suggests the importance of precise history taking, including medications usage such as NSAIDs and other risk factors.
Adult
;
Aged
;
Anti-Inflammatory Agents, Non-Steroidal
;
Colitis, Ischemic*
;
Contraceptives, Oral
;
Diuretics
;
Humans
;
Ibuprofen*
;
Inflammation
;
Intestine, Large
;
Ischemia
;
Risk Factors